PT1149831E - Processo para preparacao do sal tri-hidrato do mesilato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermediarios uteis para esse fim - Google Patents
Processo para preparacao do sal tri-hidrato do mesilato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermediarios uteis para esse fimInfo
- Publication number
- PT1149831E PT1149831E PT01303713T PT01303713T PT1149831E PT 1149831 E PT1149831 E PT 1149831E PT 01303713 T PT01303713 T PT 01303713T PT 01303713 T PT01303713 T PT 01303713T PT 1149831 E PT1149831 E PT 1149831E
- Authority
- PT
- Portugal
- Prior art keywords
- phenylpiperidin
- hydroxyphenyl
- hydroxy
- propanol
- tri
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- -1 TRI-HYDRATE SALT Chemical class 0.000 title 1
- QEMSVZNTSXPFJA-UHFFFAOYSA-N traxoprodil Chemical compound C1CC(O)(C=2C=CC=CC=2)CCN1C(C)C(O)C1=CC=C(O)C=C1 QEMSVZNTSXPFJA-UHFFFAOYSA-N 0.000 title 1
- QEMSVZNTSXPFJA-HNAYVOBHSA-N 1-[(1s,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]-4-phenylpiperidin-4-ol Chemical compound C1([C@H](O)[C@H](C)N2CCC(O)(CC2)C=2C=CC=CC=2)=CC=C(O)C=C1 QEMSVZNTSXPFJA-HNAYVOBHSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- LKGCPYOBWLSCTK-UHFFFAOYSA-N methanesulfonic acid;trihydrate Chemical compound O.O.O.CS(O)(=O)=O LKGCPYOBWLSCTK-UHFFFAOYSA-N 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20041700P | 2000-04-28 | 2000-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1149831E true PT1149831E (pt) | 2004-11-30 |
Family
ID=22741639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01303713T PT1149831E (pt) | 2000-04-28 | 2001-04-24 | Processo para preparacao do sal tri-hidrato do mesilato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermediarios uteis para esse fim |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6570018B2 (enExample) |
| EP (1) | EP1149831B1 (enExample) |
| JP (1) | JP2001354650A (enExample) |
| KR (1) | KR100432841B1 (enExample) |
| CN (1) | CN1211366C (enExample) |
| AR (1) | AR028377A1 (enExample) |
| AT (1) | ATE275130T1 (enExample) |
| AU (1) | AU781715B2 (enExample) |
| BR (1) | BR0101611A (enExample) |
| CA (1) | CA2345286C (enExample) |
| CZ (1) | CZ20011472A3 (enExample) |
| DE (1) | DE60105221T2 (enExample) |
| DK (1) | DK1149831T3 (enExample) |
| ES (1) | ES2225425T3 (enExample) |
| HK (1) | HK1040514B (enExample) |
| HU (1) | HUP0101725A3 (enExample) |
| ID (1) | ID30012A (enExample) |
| IL (1) | IL142706A0 (enExample) |
| IN (1) | IN191534B (enExample) |
| PL (1) | PL347299A1 (enExample) |
| PT (1) | PT1149831E (enExample) |
| RU (1) | RU2192415C1 (enExample) |
| SI (1) | SI1149831T1 (enExample) |
| TW (1) | TWI222440B (enExample) |
| YU (1) | YU27801A (enExample) |
| ZA (1) | ZA200103321B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6743921B2 (en) * | 2002-01-24 | 2004-06-01 | Dsm Catalytica Pharmaceuticals, Inc. | Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
| CN105037221B (zh) * | 2015-06-18 | 2017-05-10 | 吉林大学珠海学院 | 一种具有神经保护作用的化合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5272160A (en) * | 1989-05-17 | 1993-12-21 | Pfizer Inc | 2-piperidino-1-alkanol derivatives as antiischemic agents |
| ATE215072T1 (de) | 1995-08-11 | 2002-04-15 | Pfizer | (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4- phenylpiperidin-1-yl)-1-propanol-methansulfonat trihydrat |
| TW450807B (en) * | 1995-09-15 | 2001-08-21 | Pfizer | Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents |
-
2001
- 2001-04-18 YU YU27801A patent/YU27801A/sh unknown
- 2001-04-19 IL IL14270601A patent/IL142706A0/xx not_active IP Right Cessation
- 2001-04-20 IN IN357BO2001 patent/IN191534B/en unknown
- 2001-04-23 TW TW090109679A patent/TWI222440B/zh not_active IP Right Cessation
- 2001-04-23 US US09/840,668 patent/US6570018B2/en not_active Expired - Fee Related
- 2001-04-24 ES ES01303713T patent/ES2225425T3/es not_active Expired - Lifetime
- 2001-04-24 ZA ZA200103321A patent/ZA200103321B/xx unknown
- 2001-04-24 EP EP01303713A patent/EP1149831B1/en not_active Expired - Lifetime
- 2001-04-24 DK DK01303713T patent/DK1149831T3/da active
- 2001-04-24 PT PT01303713T patent/PT1149831E/pt unknown
- 2001-04-24 DE DE60105221T patent/DE60105221T2/de not_active Expired - Fee Related
- 2001-04-24 SI SI200130185T patent/SI1149831T1/ unknown
- 2001-04-24 AT AT01303713T patent/ATE275130T1/de not_active IP Right Cessation
- 2001-04-25 CZ CZ20011472A patent/CZ20011472A3/cs unknown
- 2001-04-26 BR BR0101611-3A patent/BR0101611A/pt not_active IP Right Cessation
- 2001-04-26 AU AU38897/01A patent/AU781715B2/en not_active Ceased
- 2001-04-26 ID IDP20010344D patent/ID30012A/id unknown
- 2001-04-26 AR ARP010101972A patent/AR028377A1/es unknown
- 2001-04-26 CA CA002345286A patent/CA2345286C/en not_active Expired - Fee Related
- 2001-04-27 KR KR10-2001-0022856A patent/KR100432841B1/ko not_active Expired - Fee Related
- 2001-04-27 HU HU0101725A patent/HUP0101725A3/hu unknown
- 2001-04-27 RU RU2001111948/04A patent/RU2192415C1/ru not_active IP Right Cessation
- 2001-04-27 CN CNB011171545A patent/CN1211366C/zh not_active Expired - Fee Related
- 2001-04-27 JP JP2001130684A patent/JP2001354650A/ja active Pending
- 2001-04-27 PL PL01347299A patent/PL347299A1/xx not_active Application Discontinuation
-
2002
- 2002-03-14 HK HK02101947.0A patent/HK1040514B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT80913B (pt) | Processo para a preparacao de novos compostos ciano-substituidos | |
| CA2383409A1 (en) | Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| BR9914167A (pt) | Composto, método de tratamento, inibição do crescimento de, ou erradicação de neoplasmas, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e processo para preparar o composto | |
| BR0206372A (pt) | Processo para sintetizar um composto | |
| GR3031200T3 (en) | Transportvehicles for macromolecules | |
| GT200200146A (es) | Nuevos compuestos fungicidas | |
| PT1125908E (pt) | Novos compostos fenólicos derivados de dialcoxietanais, seu processo de preparação e sua aplicação | |
| BR0113259A (pt) | Processo para a preparação de um composto, composto e processo para a preparação de compostos | |
| BR0007982A (pt) | Processo para a preparação de um composto, e,composto | |
| BR0009453A (pt) | Processo para a preparação de um composto | |
| BR9809809A (pt) | Processo para a preparação de um composto, e, proxetina | |
| BR0205172A (pt) | Processo para a sìntese de esfingosina | |
| BR9916382A (pt) | Processo para a preparação de um composto | |
| HU0101725D0 (en) | Process for the preparation of the mesylate trihidrate of 1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor | |
| BR0209842A (pt) | Processo para a preparação de imipenem | |
| BR9909151A (pt) | processos para preparação de intermediários | |
| BR0205164A (pt) | Processo para purificar azeotropicamente material orgânico polimerizável aquoso | |
| BR9401346A (pt) | Processo para a preparação de derivados de 4-amino-3-oxo-2,3,4,5-tetraidro-1,2,4-triazina e processo para a preparação de um composto | |
| BR0101630A (pt) | Processo para a preparação do trihidrato do salmesilato de1-(4-hidroxifenil)-2(4-hidróxi-4fenilpiperidin-1-il)-1-propanol | |
| BR0008352A (pt) | Composto quìmico, e, processo para produzir um composto | |
| BR9914775A (pt) | Processo quìmico para preparação deintermediários | |
| BR0113944A (pt) | Processo para a produção de compostos quirais | |
| PT1234817E (pt) | Processo para a preparacao de midodrina | |
| BR9902525A (pt) | Processo para compostos de ácido pirrolidinil-hidroxâmico | |
| BR9509752A (pt) | Composto e processo para preparar um composto |